- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Allison Silvers Discusses the Importance of Palliative Care Integration for Complex Patients
Palliative care can help alleviate the suffering and symptoms that go along with serious disease, making it an important component when caring for complex, high-need patients, said Allison Silvers, vice president of payment and policy at the Center to Advance Palliative Care.
Palliative care can help alleviate the suffering and symptoms that go along with serious disease, making it an important component when caring for complex, high-need patients, said Allison Silvers, vice president of payment and policy at the Center to Advance Palliative Care.
Transcript (slightly modified)
Why is it important to increase access to palliative care for complex and high need patients?
Well, that’s an easy question. I think every complex, high-need, seriously ill patient should have palliative care. What palliative care really boils down to is relieving any suffering that goes along with having that complex or serious need, so it should be part and parcel. There’s pain that goes along with a lot of conditions, there’s a variety of other symptoms, there’s functional impairment, so even with things like COPD, you suddenly become limited in what you can do, maybe not so suddenly sometimes, there’s obviously a lot of gradual deterioration in populations as well.
But there are ways to relieve the pain, the symptoms, to get support for the places where you need support. So I think palliative care needs to be just completely integrated into the care of seriously ill and complex populations.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
